| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Pelthos Therapeutics Inc.
13D/A
PTHS · 171126204
|
49.9% |
11/3/2026
Event 10/30/2026
|
||||
|
Xoma Royalty Corporation
13D
XOMA · 98419J206
|
47.0% |
5/1/2026
Event 4/27/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.